Triple negative breast cancer (TNBC), a subtype that does not express estrogen receptor (ER) or progesterone receptor (PR) and in which human epidermal growth factor receptor 2 (HER2) is not amplified, is very aggressive, usually affecting young women and representing 15–20% of all cases of breast cancer. This evidence concerns the gene PGR and breast carcinoma.